Neuro 3d's €31.5 million third round late in 2004 was one of France's largest private biotech financings for years. But none of the investors are looking to France to provide the exit opportunities, which are more likely to be found in M&A, or in Switzerland.

Neuro 3d's €31.5 million third round late in 2004 was one of France's largest private biotech financings for years. But none of the investors are looking to France to provide the exit opportunities, which are more likely to be found in M&A, or in Switzerland.

Summarizing the month in European dealmaking.

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, Hospital-Acquired Infections, features profiles of Entomed SA, Infectio Diagnostic Inc., MedMined Inc. and Microbia Inc. Plus these Selected Start-Ups across Health Care: Cardio-optics Inc., Immunocept LLC, Nucleotech LLC and Xenerate AB.